In a study where R-2HG was shown to attenuate aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis(Qing et al. 2021), it was found that PFKP promotes glycolysis and exerts an oncogenic role in leukemia. This evidence concerns the gene FTO and leukemia.